Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications

Teresa Padro1, Natalia Muñoz-Garcia1, Esther Peña1

  • 1Cardiovascular-Program ICCC, Research Institute Hospital Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.

Insights

Cardiovascular diseases (CVD) affect men and women differently. This review explores how non-traditional risk factors, like inflammation and genetics, contribute to sex-specific atherosclerosis and CVD outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Sex Differences in Disease
  • Atherosclerosis Research

Background:

  • Cardiovascular diseases (CVD) are a leading cause of death globally, with distinct prognoses and outcomes between sexes.
  • While conventional risk factors are known, non-traditional factors are crucial for understanding residual CVD risk.
  • Sex-specific differences in CVD pathophysiology, presentation, prevalence, and outcomes are increasingly recognized.

Purpose of the Study:

  • To review current knowledge on sex differences in atherosclerotic plaque composition and clinical evolution.
  • To analyze the role of non-traditional risk factors in sex-specific atherosclerosis.
  • To discuss the impact of female-specific disorders on CVD.

Main Methods:

  • Literature review summarizing current research on sex differences in CVD.
  • Analysis of non-traditional risk factors including inflammation, lipoprotein(a), hemostasis, intraplaque calcification, and depression.
  • Exploration of sex-differential impacts of chronic infections, gut microbiome, and epigenetics.

Main Results:

  • Sex-specificities in non-traditional risk factors significantly influence atherosclerosis development and clinical manifestations.
  • Factors like inflammation, lipoprotein(a), hemostasis, intraplaque calcification, and depression exhibit sex-differential effects on CVD.
  • Chronic infections, gut microbiome, and epigenetic regulation show potential sex-differential impacts on atherosclerosis.

Conclusions:

  • Understanding sex differences in non-traditional risk factors is essential for personalized CVD prevention and treatment.
  • Further research is needed to elucidate the mechanisms behind sex-specific atherosclerosis and CVD.
  • Addressing female-specific disorders is critical for improving CVD outcomes in women.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
511
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
266
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
201
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
221
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
200